Annual Net Income
-$338.79 M
-$254.97 M-304.21%
December 31, 2023
Summary
- As of February 10, 2025, SYRE annual net profit is -$338.79 million, with the most recent change of -$254.97 million (-304.21%) on December 31, 2023.
- During the last 3 years, SYRE annual net income has fallen by -$257.90 million (-318.81%).
- SYRE annual net income is now -3174.28% below its all-time high of -$10.35 million, reached on December 1, 2014.
Performance
SYRE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$69.03 M
-$30.19 M-77.74%
September 30, 2024
Summary
- As of February 10, 2025, SYRE quarterly net profit is -$69.03 million, with the most recent change of -$30.19 million (-77.74%) on September 30, 2024.
- Over the past year, SYRE quarterly net income has dropped by -$28.92 million (-72.11%).
- SYRE quarterly net income is now -4737.28% below its all-time high of -$1.43 million, reached on June 1, 2015.
Performance
SYRE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$214.90 M
-$28.92 M-15.55%
September 30, 2024
Summary
- As of February 10, 2025, SYRE TTM net profit is -$214.90 million, with the most recent change of -$28.92 million (-15.55%) on September 30, 2024.
- Over the past year, SYRE TTM net income has increased by +$79.53 million (+27.01%).
- SYRE TTM net income is now -14038.29% below its all-time high of -$1.52 million, reached on March 1, 2014.
Performance
SYRE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SYRE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -304.2% | -72.1% | +27.0% |
| 3 y3 years | -318.8% | -278.6% | -151.5% |
| 5 y5 years | -663.9% | -278.6% | -151.5% |
SYRE Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -414.9% | at low | -278.6% | +68.2% | -226.6% | +41.0% |
| 5 y | 5-year | -414.9% | at low | -910.7% | +68.2% | -226.6% | +41.0% |
| alltime | all time | -3174.3% | at low | -4737.3% | +68.2% | <-9999.0% | +41.0% |
Spyre Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$69.03 M(+77.7%) | -$214.90 M(+15.6%) |
| Jun 2024 | - | -$38.84 M(-11.4%) | -$185.98 M(-48.9%) |
| Mar 2024 | - | -$43.86 M(-30.6%) | -$364.23 M(+7.5%) |
| Dec 2023 | -$338.79 M(+304.2%) | -$63.18 M(+57.5%) | -$338.79 M(+15.1%) |
| Sep 2023 | - | -$40.11 M(-81.5%) | -$294.43 M(+8.0%) |
| Jun 2023 | - | -$217.08 M(+1078.4%) | -$272.56 M(+250.3%) |
| Mar 2023 | - | -$18.42 M(-2.1%) | -$77.80 M(-7.2%) |
| Dec 2022 | -$83.81 M(+27.4%) | - | - |
| Dec 2022 | - | -$18.82 M(+3.2%) | -$83.81 M(-1.9%) |
| Sep 2022 | - | -$18.23 M(-18.3%) | -$85.44 M(-2.4%) |
| Jun 2022 | - | -$22.32 M(-8.6%) | -$87.51 M(+21.5%) |
| Mar 2022 | - | -$24.44 M(+19.5%) | -$72.02 M(+9.4%) |
| Dec 2021 | -$65.80 M(-18.7%) | -$20.45 M(+0.7%) | -$65.80 M(-3.3%) |
| Sep 2021 | - | -$20.31 M(+197.3%) | -$68.07 M(+3.5%) |
| Jun 2021 | - | -$6.83 M(-62.5%) | -$65.80 M(-18.1%) |
| Mar 2021 | - | -$18.22 M(-19.8%) | -$80.38 M(-0.6%) |
| Dec 2020 | -$80.89 M(+3.4%) | -$22.71 M(+26.0%) | -$80.89 M(+1.5%) |
| Sep 2020 | - | -$18.03 M(-15.8%) | -$79.67 M(-4.3%) |
| Jun 2020 | - | -$21.42 M(+14.4%) | -$83.21 M(+4.3%) |
| Mar 2020 | - | -$18.73 M(-12.9%) | -$79.81 M(+2.0%) |
| Dec 2019 | -$78.25 M | -$21.50 M(-0.4%) | -$78.25 M(+9.2%) |
| Sep 2019 | - | -$21.57 M(+19.7%) | -$71.66 M(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$18.02 M(+5.0%) | -$62.00 M(+16.1%) |
| Mar 2019 | - | -$17.17 M(+15.2%) | -$53.40 M(+20.4%) |
| Dec 2018 | -$44.35 M(+62.8%) | -$14.90 M(+25.0%) | -$44.35 M(+23.4%) |
| Sep 2018 | - | -$11.92 M(+26.6%) | -$35.93 M(+12.7%) |
| Jun 2018 | - | -$9.41 M(+16.0%) | -$31.89 M(+9.6%) |
| Mar 2018 | - | -$8.12 M(+25.2%) | -$29.11 M(+6.9%) |
| Dec 2017 | -$27.24 M(+25.5%) | -$6.48 M(-17.7%) | -$27.24 M(+3.8%) |
| Sep 2017 | - | -$7.87 M(+18.7%) | -$26.24 M(+6.7%) |
| Jun 2017 | - | -$6.63 M(+6.2%) | -$24.60 M(+5.1%) |
| Mar 2017 | - | -$6.25 M(+13.9%) | -$23.40 M(+7.8%) |
| Dec 2016 | -$21.70 M(+92.1%) | -$5.48 M(-12.1%) | -$21.70 M(+7.4%) |
| Sep 2016 | - | -$6.24 M(+14.9%) | -$20.20 M(+16.3%) |
| Jun 2016 | - | -$5.43 M(+19.4%) | -$17.38 M(+29.9%) |
| Mar 2016 | - | -$4.55 M(+14.0%) | -$13.37 M(+18.4%) |
| Dec 2015 | -$11.29 M(+9.2%) | -$3.99 M(+16.8%) | -$11.29 M(+7.7%) |
| Sep 2015 | - | -$3.41 M(+139.2%) | -$10.49 M(+1.6%) |
| Jun 2015 | - | -$1.43 M(-42.2%) | -$10.33 M(-8.6%) |
| Mar 2015 | - | -$2.47 M(-22.4%) | -$11.29 M(+9.2%) |
| Dec 2014 | -$10.35 M | -$3.18 M(-2.1%) | -$10.35 M(+44.4%) |
| Sep 2014 | - | -$3.25 M(+35.6%) | -$7.17 M(+83.0%) |
| Jun 2014 | - | -$2.40 M(+57.6%) | -$3.92 M(+157.6%) |
| Mar 2014 | - | -$1.52 M | -$1.52 M |
FAQ
- What is Spyre Therapeutics annual net profit?
- What is the all time high annual net income for Spyre Therapeutics?
- What is Spyre Therapeutics annual net income year-on-year change?
- What is Spyre Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly net income year-on-year change?
- What is Spyre Therapeutics TTM net profit?
- What is the all time high TTM net income for Spyre Therapeutics?
- What is Spyre Therapeutics TTM net income year-on-year change?
What is Spyre Therapeutics annual net profit?
The current annual net income of SYRE is -$338.79 M
What is the all time high annual net income for Spyre Therapeutics?
Spyre Therapeutics all-time high annual net profit is -$10.35 M
What is Spyre Therapeutics annual net income year-on-year change?
Over the past year, SYRE annual net profit has changed by -$254.97 M (-304.21%)
What is Spyre Therapeutics quarterly net profit?
The current quarterly net income of SYRE is -$69.03 M
What is the all time high quarterly net income for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly net profit is -$1.43 M
What is Spyre Therapeutics quarterly net income year-on-year change?
Over the past year, SYRE quarterly net profit has changed by -$28.92 M (-72.11%)
What is Spyre Therapeutics TTM net profit?
The current TTM net income of SYRE is -$214.90 M
What is the all time high TTM net income for Spyre Therapeutics?
Spyre Therapeutics all-time high TTM net profit is -$1.52 M
What is Spyre Therapeutics TTM net income year-on-year change?
Over the past year, SYRE TTM net profit has changed by +$79.53 M (+27.01%)